Takeda (TAK) Chief Transformation Officer Duprey Sells 47,586 Shares

What Happened

• Lauren Duprey Rusckowski, Chief Transformation Officer at Takeda Pharmaceutical Co. Ltd. (TAK), sold 47,586 shares in an open-market transaction on August 10, 2026. The reported weighted-average price was $17.10 per share, for aggregate proceeds of approximately $813,721. This transaction is a sale (code S) and appears to be a routine disposition rather than a purchase.

Key Details

• Transaction date: 2026-08-10; reported filing date: 2026-08-12 (timely filed within Form 4 deadlines).
• Price: weighted average $17.10 per share; total proceeds ~$813,721.
• Shares owned after transaction: not disclosed in the provided filing summary.
• Footnote F1: Sale was a mandatory sale to cover taxes on vested equity awards (tax withholding).
• Footnote F2: Reported price is a weighted average; the filer can provide a breakdown of shares sold at each price on request.
• Transaction type: S = Sale; related to tax-withholding on vested awards (routine).

Context

• Tax-withholding sales are common when equity awards vest; they are administrative and do not necessarily indicate the insider’s view on the company’s prospects. The weighted-average price note suggests the sale may have executed in multiple trades/prices; the filer offers to provide per-price details if requested.